ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
-0,04%
Bitcoin
63.460,28
0,08%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) News

AXGN Axogen Inc

6,63
0,11 (1,69%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Axogen Inc AXGN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,11 1,69% 6,63 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,53 6,4301 6,70 6,63 6,52
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202413:00GLOBEAxogen, Inc. to Report First Quarter 2024 Financial Results..
08.3.202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:38EDGAR2Form 8-K - Current report
08.3.202400:12EDGAR2Form 144 - Report of proposed sale of securities
07.3.202422:18EDGAR2Form 144 - Report of proposed sale of securities
06.3.202414:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
06.3.202414:53EDGAR2Form S-3 - Registration statement under Securities Act of..
06.3.202414:45EDGAR2Form POS AM - Post-Effective amendments for registration..
05.3.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:29EDGAR2Form 8-K - Current report
05.3.202413:16EDGAR2Form 8-K - Current report
05.3.202413:00GLOBEAxogen, Inc Reports 2023 Fourth Quarter and Full-Year..
23.2.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202421:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:30GLOBEAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year..
12.2.202419:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.2.202423:06EDGAR2Form 144 - Report of proposed sale of securities
02.2.202422:15GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
02.2.202415:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18.1.202423:00GLOBEAxogen, Inc. Announces Positive Topline Results from REPOSE,..
11.1.202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202423:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
11.1.202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.1.202413:05EDGAR2Form 8-K - Current report
05.1.202423:21EDGAR2Form 8-K/A - Current report: [Amend]
04.1.202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
04.1.202422:56EDGAR2Form 8-K - Current report
04.1.202422:45GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..
04.1.202422:40GLOBEAxogen Announces Plan for Leadership Transition with CEO..
04.1.202422:35GLOBEAxogen Announces Promotions on Research and Development Team
26.12.202322:21EDGAR2Form 8-K - Current report
26.12.202322:15GLOBEAxogen, Inc. Appoints Kathy Weiler to its Board of Directors
13.12.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202322:38EDGAR2Form 144 - Report of proposed sale of securities
06.12.202313:15EDGAR2Form 8-K - Current report
06.12.202313:00GLOBEAxogen Announces Transition of Finance Team Leadership
01.12.202323:00GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
20.11.202313:00GLOBEAxogen, Inc. to Participate at the Piper Sandler 35th Annual..
07.11.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:13EDGAR2Form 8-K - Current report
07.11.202313:00GLOBEAxogen, Inc. Reports 2023 Third Quarter Financial Results
18.10.202313:00GLOBEAxogen, Inc. to Report Third Quarter 2023 Financial Results..
14.10.202302:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.10.202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.10.202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.10.202302:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
AXGN
Axogen
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten